Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

298 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Good syndrome: an adult-onset immunodeficiency remarkable for its high incidence of invasive infections and autoimmune complications.
Malphettes M, Gérard L, Galicier L, Boutboul D, Asli B, Szalat R, Perlat A, Masseau A, Schleinitz N, Le Guenno G, Viallard JF, Bonnotte B, Thiercelin-Legrand MF, Sanhes L, Borie R, Georgin-Lavialle S, Fieschi C, Oksenhendler E; DEFicit Immunitaire de l'adulte Study Group. Malphettes M, et al. Among authors: bonnotte b. Clin Infect Dis. 2015 Jul 15;61(2):e13-9. doi: 10.1093/cid/civ269. Epub 2015 Mar 31. Clin Infect Dis. 2015. PMID: 25828999
Late-onset combined immune deficiency: a subset of common variable immunodeficiency with severe T cell defect.
Malphettes M, Gérard L, Carmagnat M, Mouillot G, Vince N, Boutboul D, Bérezné A, Nove-Josserand R, Lemoing V, Tetu L, Viallard JF, Bonnotte B, Pavic M, Haroche J, Larroche C, Brouet JC, Fermand JP, Rabian C, Fieschi C, Oksenhendler E; DEFI Study Group. Malphettes M, et al. Among authors: bonnotte b. Clin Infect Dis. 2009 Nov 1;49(9):1329-38. doi: 10.1086/606059. Clin Infect Dis. 2009. PMID: 19807277
B-cell and T-cell phenotypes in CVID patients correlate with the clinical phenotype of the disease.
Mouillot G, Carmagnat M, Gérard L, Garnier JL, Fieschi C, Vince N, Karlin L, Viallard JF, Jaussaud R, Boileau J, Donadieu J, Gardembas M, Schleinitz N, Suarez F, Hachulla E, Delavigne K, Morisset M, Jacquot S, Just N, Galicier L, Charron D, Debré P, Oksenhendler E, Rabian C; DEFI Study Group. Mouillot G, et al. J Clin Immunol. 2010 Sep;30(5):746-55. doi: 10.1007/s10875-010-9424-3. Epub 2010 May 1. J Clin Immunol. 2010. PMID: 20437084
Efficacy and safety of rituximab in common variable immunodeficiency-associated immune cytopenias: a retrospective multicentre study on 33 patients.
Gobert D, Bussel JB, Cunningham-Rundles C, Galicier L, Dechartres A, Berezne A, Bonnotte B, DeRevel T, Auzary C, Jaussaud R, Larroche C, LeQuellec A, Ruivard M, Seve P, Smail A, Viallard JF, Godeau B, Hermine O, Michel M. Gobert D, et al. Among authors: bonnotte b. Br J Haematol. 2011 Nov;155(4):498-508. doi: 10.1111/j.1365-2141.2011.08880.x. Epub 2011 Oct 8. Br J Haematol. 2011. PMID: 21981575 Free PMC article.
Efficiency of immunoglobulin G replacement therapy in common variable immunodeficiency: correlations with clinical phenotype and polymorphism of the neonatal Fc receptor.
Gouilleux-Gruart V, Chapel H, Chevret S, Lucas M, Malphettes M, Fieschi C, Patel S, Boutboul D, Marson MN, Gérard L, Lee M, Watier H, Oksenhendler E; DEFI study group. Gouilleux-Gruart V, et al. Clin Exp Immunol. 2013 Feb;171(2):186-94. doi: 10.1111/cei.12002. Clin Exp Immunol. 2013. PMID: 23286945 Free PMC article.
Efficacy and safety of rituximab given at 1,000 mg on days 1 and 15 compared to the standard regimen to treat adult immune thrombocytopenia.
Mahévas M, Ebbo M, Audia S, Bonnotte B, Schleinitz N, Durand JM, Chiche L, Khellaf M, Bierling P, Roudot-Thoraval F, Godeau B, Michel M. Mahévas M, et al. Among authors: bonnotte b. Am J Hematol. 2013 Oct;88(10):858-61. doi: 10.1002/ajh.23518. Epub 2013 Sep 3. Am J Hematol. 2013. PMID: 23798363 Free article. Clinical Trial.
Emergence of long-lived autoreactive plasma cells in the spleen of primary warm auto-immune hemolytic anemia patients treated with rituximab.
Mahévas M, Michel M, Vingert B, Moroch J, Boutboul D, Audia S, Cagnard N, Ripa J, Menard C, Tarte K, Mégret J, Le Gallou S, Patin P, Thai L, Galicier L, Bonnotte B, Godeau B, Noizat-Pirenne F, Weill JC, Reynaud CA. Mahévas M, et al. Among authors: bonnotte b. J Autoimmun. 2015 Aug;62:22-30. doi: 10.1016/j.jaut.2015.05.006. Epub 2015 Jun 23. J Autoimmun. 2015. PMID: 26112660
Immune thrombocytopenia in adults: a prospective cohort study of clinical features and predictors of outcome.
Grimaldi-Bensouda L, Nordon C, Michel M, Viallard JF, Adoue D, Magy-Bertrand N, Durand JM, Quittet P, Fain O, Bonnotte B, Morin AS, Morel N, Costedoat-Chalumeau N, Pan-Petesch B, Khellaf M, Perlat A, Sacre K, Lefrere F, Abenhaim L, Godeau B; Group for the PGRx-ITP Study. Grimaldi-Bensouda L, et al. Among authors: bonnotte b. Haematologica. 2016 Sep;101(9):1039-45. doi: 10.3324/haematol.2016.146373. Epub 2016 May 26. Haematologica. 2016. PMID: 27229715 Free PMC article.
298 results